Mererid Evans

6.2k total citations
40 papers, 1.0k citations indexed

About

Mererid Evans is a scholar working on Otorhinolaryngology, Surgery and Oncology. According to data from OpenAlex, Mererid Evans has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Otorhinolaryngology, 15 papers in Surgery and 14 papers in Oncology. Recurrent topics in Mererid Evans's work include Head and Neck Cancer Studies (24 papers), Esophageal Cancer Research and Treatment (7 papers) and Head and Neck Surgical Oncology (5 papers). Mererid Evans is often cited by papers focused on Head and Neck Cancer Studies (24 papers), Esophageal Cancer Research and Treatment (7 papers) and Head and Neck Surgical Oncology (5 papers). Mererid Evans collaborates with scholars based in United Kingdom, United States and Germany. Mererid Evans's co-authors include Matthew Beasley, Ned Powell, Stephen Man, Chris Hurt, Max Robinson, Nachi Palaniappan, Katherine A. Hutcheson, Emma Parsons, Leszek K. Borysiewicz and Terence M. Jones and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Mererid Evans

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mererid Evans United Kingdom	15	387	335	290	260	181	40	1.0k
Ned Powell United Kingdom	20	696 1.8×	641 1.9×	314 1.1×	44 0.2×	241 1.3×	43	1.5k
Anna Laury United States	20	282 0.7×	495 1.5×	447 1.5×	134 0.5×	378 2.1×	34	1.9k
Siddharth Sheth United States	16	223 0.6×	133 0.4×	260 0.9×	68 0.3×	117 0.6×	60	607
Cai Xu China	19	34 0.1×	405 1.2×	372 1.3×	126 0.5×	394 2.2×	79	1.2k
Steven M. Sperry United States	16	309 0.8×	254 0.8×	182 0.6×	43 0.2×	107 0.6×	23	848
Monica Morris United States	15	212 0.5×	225 0.7×	149 0.5×	55 0.2×	527 2.9×	38	1.2k
P. Wilson United Kingdom	17	82 0.2×	170 0.5×	205 0.7×	155 0.6×	110 0.6×	29	707
Kristina R. Dahlstrom United States	28	1.4k 3.7×	746 2.2×	651 2.2×	62 0.2×	353 2.0×	66	2.3k
Hélène Péré France	20	182 0.5×	266 0.8×	551 1.9×	473 1.8×	156 0.9×	84	1.8k
Inas Elattar Egypt	17	91 0.2×	575 1.7×	356 1.2×	25 0.1×	248 1.4×	43	1.1k

Countries citing papers authored by Mererid Evans

Since Specialization

Citations

This map shows the geographic impact of Mererid Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mererid Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mererid Evans more than expected).

Fields of papers citing papers by Mererid Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mererid Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mererid Evans. The network helps show where Mererid Evans may publish in the future.

Co-authorship network of co-authors of Mererid Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Mererid Evans. A scholar is included among the top collaborators of Mererid Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mererid Evans. Mererid Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shaw, Richard, Ruth Knight, Anastasios Kanatas, et al.. (2025). RAPTOR: Randomised Controlled Trial of PENTOCLO (pentoxifylline-tocopherol-clodronate) in Mandibular Osteoradionecrosis—study protocol for an open-label phase II randomised controlled superiority trial. Trials. 26(1). 254–254.

Evans, Mererid, Chris Hurt, Abhishek Mahajan, et al.. (2025). Correlation between imaging-detected and pathological extranodal extension in a randomised trial in Human Papillomavirus-positive oropharyngeal cancer. British Journal of Cancer. 134(3). 428–438.

Evans, Mererid, Pierluigi Bonomo, Melvin L.K. Chua, et al.. (2025). Post-operative radiotherapy for oral cavity squamous cell carcinoma: Review of the data guiding the selection and the delineation of post-operative target volumes. Radiotherapy and Oncology. 207. 110880–110880. 3 indexed citations

Palaniappan, Nachi, et al.. (2024). High-grade neuroendocrine head and neck cancer: Case series and review of the literature. Current Problems in Cancer. 51. 101105–101105. 1 indexed citations

Kanatas, Anastasios, Stefano Fedele, Vinod Patel, et al.. (2024). RAPTOR: Randomised Controlled Trial of PENTOCLO in Mandibular Osteoradionecrosis. European Journal of Surgical Oncology. 50(1). 107194–107194. 1 indexed citations

O’Hara, James, Chris Hurt, Joanne Patterson, et al.. (2024). Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma. JAMA Otolaryngology–Head & Neck Surgery. 150(11). 1002–1002. 2 indexed citations

Ottensmeier, Christian H., Mererid Evans, Emma V. King, et al.. (2021). 437 A multicentre phase 1b study of NG-641, a novel transgene-armed and tumour-selective adenoviral vector, and pembrolizumab as neoadjuvant treatment for squamous cell carcinoma of the head and neck. Regular and Young Investigator Award Abstracts. A467–A467. 4 indexed citations

Gestel, Dirk Van, Tatiana Dragan, Vincent Grégoire, Mererid Evans, & Volker Budach. (2020). Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology. 10. 282–282. 10 indexed citations

Hanna, Louise, et al.. (2019). A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy. Radiation Oncology. 14(1). 57–57. 35 indexed citations

10.

Beasley, Matthew, et al.. (2019). Deintensification of Adjuvant Treatment After Transoral Surgery in Patients With Human Papillomavirus-Positive Oropharyngeal Cancer: The Conception of the PATHOS Study and Its Development. Frontiers in Oncology. 9. 936–936. 40 indexed citations

11.

Holzhauser, Stefan, David M. Owens, Adam Christian, et al.. (2018). Sensitivity to inhibition of DNA repair by Olaparib in novel oropharyngeal cancer cell lines infected with Human Papillomavirus. PLoS ONE. 13(12). e0207934–e0207934. 14 indexed citations

12.

Simon, Christian, Carmela Caballero, Catherine Fortpied, et al.. (2018). BEST OF: A phase III study assessing the best of radiotherapy (Intensity Modulated RadioTherapy, IMRT) compared to the best of surgery (Trans-Oral Surgery, TOS) in patients with T1-T2, N0 oropharyngeal squamous cell carcinoma (OPSCC).. Journal of Clinical Oncology. 36(15_suppl). TPS6098–TPS6098. 1 indexed citations

13.

Hendry, Maggie, Diana Pasterfield, Simon Gollins, et al.. (2017). Talking about human papillomavirus and cancer: development of consultation guides through lay and professional stakeholder coproduction using qualitative, quantitative and secondary data. BMJ Open. 7(6). e015413–e015413. 9 indexed citations

14.

Hendry, Maggie, Richard Adams, Mererid Evans, et al.. (2016). Talking about human papillomavirus and cancer: protocol for a patient-centred study to develop scripted consultations. BMJ Open. 6(4). e011205–e011205. 3 indexed citations

15.

Nutting, Christopher M., James P. Morden, Matthew Beasley, et al.. (2016). First results of COSTAR: A randomised trial of 3-dimensional conformal radiotherapy (3DCRT) vs cochlea-sparing intensity modulated radiotherapy (CS-IMRT) in patients with parotid cancer.. Journal of Clinical Oncology. 34(15_suppl). 6006–6006. 3 indexed citations

16.

Hurt, Chris, Emma Parsons, Sarah Townsend, et al.. (2015). PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 15(1). 602–602. 181 indexed citations

17.

Al‐Taei, Saly, Ned Powell, Mererid Evans, et al.. (2013). Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy. Cancer Immunology Immunotherapy. 62(12). 1821–1830. 17 indexed citations

18.

Dehn, Tom, Tom Crosby, Mererid Evans, Richard Gillies, & Nicholas Maynard. (2009). The Management of a Patient with an Operable Carcinoma of the Oesophagus. Annals of The Royal College of Surgeons of England. 91(5). 366–370. 18 indexed citations

19.

Youde, Sarah J., et al.. (2008). HPV16 E6_29‐38‐specific T cells kill cervical carcinoma cells despite partial evasion of T‐cell effector function. International Journal of Cancer. 122(12). 2791–2799. 13 indexed citations

20.

Velders, Markwin P., Sanne Weijzen, Gretchen L. Eiben, et al.. (2001). Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine. The Journal of Immunology. 166(9). 5366–5373. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact